Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  Pharmaceutical intermediates >  Bulk Drug Intermediates >  methyl ibogamine-18-carboxylate

methyl ibogamine-18-carboxylate

Basic information Safety Supplier Related

methyl ibogamine-18-carboxylate Basic information

Product Name:
methyl ibogamine-18-carboxylate
Synonyms:
  • methyl ibogamine-18-carboxylate
  • coronardine
  • (-)-Ibogamine-18-carboxylic acid methyl ester
  • Ibogamine-18-carboxylic acid methyl ester
  • Coronaridin
  • NSC 127490
  • methyl ibogamine
CAS:
467-77-6
MF:
C21H26N2O2
MW:
338.448
EINECS:
207-398-7
Mol File:
467-77-6.mol
More
Less

methyl ibogamine-18-carboxylate Chemical Properties

Melting point:
92-93 °C
Boiling point:
488.1±45.0 °C(Predicted)
Density 
1.24±0.1 g/cm3(Predicted)
storage temp. 
4°C, protect from light
pka
16?+-.0.60(Predicted)
form 
Solid
color 
White to off-white
More
Less

methyl ibogamine-18-carboxylate Usage And Synthesis

Uses

Ibogamine-18-carboxylic Acid Methyl Ester (CAS# 467-77-6) is a useful research chemical compound. It is used in the biosynthesis of anti-addiction agent from iboga plant.

Definition

ChEBI: (-)-coronaridine is a monoterpenoid indole alkaloid with formula C21H26N2O2. It is isolated from the flowering plant genus, Tabernaemontana. It has a role as an antileishmanial agent, an antineoplastic agent, an apoptosis inducer and a plant metabolite. It is a monoterpenoid indole alkaloid, a methyl ester, an organic heteropentacyclic compound and an alkaloid ester. It is a conjugate base of a (-)-coronaridine(1+).

Biological Activity

Coronaridine, an iboga type alkaloid, inhibits the wnt signaling pathway by decreasing β-catenin expression[1]. Coronaridine (0-40 μM; 24 hours) is against non-cancer cells with IC50 values >40 μM. It agaisnt wnt-dependent cells with IC50 values of 10.4, 11.6 and 24.4 μM for SW480, HCT116 and DLD1cells, respectively[1].Coronaridine (0-40 μM; 24 hours) inhibits β-catenin expression, but the protein levels of p-β--catenin at Ser33, Ser37, and Thr41 and p-β-catenin at Ser 45 [p-b-catenin (S45)] are unchanged[1].In whole-cell patch clamp recordings,Catharanthine (1-300 μM) are respectively co-applied with GABA at concentrations corresponding to the EC30 value for each receptor subtype. Both congeners potentiated different GABAARs in a concentration-dependent manner[2].At higher concentrations, however, Catharanthine starts to inhibit GABA-activated currents due to the reduced amplitude and rebound current, where the threshold concentration depended on the receptor subtype (e.g., > 30 μM for hα1β2; > 100 μM for hα1β2γ2 and hα2β2γ2). The PAM activity of Catharanthine's are depended on the receptor subtype: hα1β2 (4.6±0.8 μM), >hα2β2γ2 (12.6±3.8 μM), hα1β2γ2 (14.4 ± 4.6 μM)[2].

References

[1]. Kensuke Ohishi, et al. Coronaridine, an iboga type alkaloid from Tabernaemontana divaricata, inhibits the Wnt signaling pathway by decreasing β-catenin mRNA expression. Bioorg Med Chem Lett. 2015 Sep 15;25(18):3937-40. [2]. Hugo R Arias, et al. Coronaridine congeners potentiate GABA A receptors and induce sedative activity in mice in a benzodiazepine-insensitive manner. Prog Neuropsychopharmacol Biol Psychiatry. 2020 Jul 13;101:109930

methyl ibogamine-18-carboxylateSupplier

ALB Technology Limited
Tel
702-983-3769
Email
sales@albtechnology.com
Wuhan ChemFaces Biochemical Co., Ltd.
Tel
18607101326 15172504745
Email
aileen@chemfaces.com
EMMX Biotechnology LLC
Tel
888-539-0666
Email
info@emmx.com
Shanghai YuanYe Biotechnology Co., Ltd.
Tel
021-61312847; 18021002903
Email
3008007409@qq.com
Shanghai ChengShao Biological Technology Co., Ltd.
Tel
021-61847300 13341622919
Email
shcss01@163.com